Invivo Therapeutics Holdings is a medical device company that utilizes polymers as a platform technology to develop treatments to improve function in individuals paralyzed from traumatic spinal cord injuries. The company’s products are intended to protect the spinal cord after primary injury by mitigating the bleeding, inflammation, and further cell death that result from the body’s immune response to SCI. For more information visit the company’s Web site at: www.invivotherapeutics.com.

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: